Summary
The cause of Li-Fraumeni syndrome, a rare group syndrome of familial cancers, has recently been identified. Patients with this inherited condition are highly susceptible to specific neoplasms, including early-onset breast cancers. The available evidence links Li-Fraumeni syndrome to inherited mutations of the tumor suppressor gene p53. Moreover, somatically acquired p53 mutations and gene deletions are common feature in breast cancer of sporadic origin. These findings suggest that germline p53 mutations are important in familial and, possibly sporadic, breast tumors. We have therefore screened lymphocyte DNA from 19 unrelated bilateral cancer patients for germline p53 mutations in exons 5, 6, 7 and 8. We have however detected no germline mutations by means of the single-strand confirmation polymorphism technique in any of the lymphocyte DNAs examined and conclude that p53 mutations are not generally involved in bilateral breast cancer.
References
Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson Hamilton S, Vogelstein B (1990) p53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717–7722
Bartek J, Iggo R, Gannon J, Lane DP (1990) Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893–899
Chaudary MA, Millis RR, Bulbrook RD, Hayward JL (1985) Family history and bilateral primary breast cancer. Breast Cancer Res Treat 5:201–205
Crook T, Wrede D, Vousden KH (1991) p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 5:673–675
Cropp CS, Lidereau R, Campbell G, Champeme MH, Callahan R (1990) Loss of heterozygosity on chromosome 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci USA 87:7737–7741
Devilee P, Van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL, Cornelisse CJ (1989) At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5:554–560
Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820
Li FP, Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer and other neoplasms. A familial syndrome? Ann Intern Med 71:747–752
Lynch HT, Lynch JF (1985) Breast cancer genetics. In: Müller H, Weber W (eds) Familial cancer. Karger, Basel, pp 20–24
Mackay J, Steel CM, Elder PA, Forrest APM, Evans HJ (1988) Allele loss on short arm of chromosome 17 in breast cancers. Lancet II:1384–1385
Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705–708
Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and DNA polymorphism using the polymerase chain reaction. Genomics 5:874–879
Prosser J, Elder PA, Condie A, MacFadyen I, Steel CM, Evans HJ (1991) Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br J Cancer 63:181–184
Soussi T, Caron de Fromentel C, May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945–952
Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749
Thompson AM, Steel CM, Chety U, Hawkins RA, Miller WR, Carter DC, Forrest APM, Evans HJ (1990) p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer 61:74–78
Werness BA, Levine AJ, Howley PM (1990) Association of human papillomavirus type-16 and type-18 E6 proteins with P53. Science 248:76–79
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lidereau, R., Soussi, T. Absence of p53 germ-line mutations in bilateral breast cancer patients. Hum Genet 89, 250–252 (1992). https://doi.org/10.1007/BF00217135
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00217135